Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial

Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous... J Clin Immunol (2017) 37:548–558 DOI 10.1007/s10875-017-0422-6 ORIGINAL ARTICLE Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial 1 2 2 2 2 Mark Parta & Corin Kelly & Nana Kwatemaa & Narda Theobald & Diane Hilligoss & 3 4 5 5,6 2 Jing Qin & Douglas B. Kuhns & Christa Zerbe & Steven M. Holland & Harry Malech & Elizabeth M. Kang Received: 20 February 2017 /Accepted: 13 July 2017 /Published online: 28 July 2017 US Government (outside the USA) 2017 Abstract dose total body irradiation for MUD recipients) with sirolimus Purpose The purpose of this study was to evaluate engraft- graft-versus-host disease prophylaxis. ment and adverse events with a conditioning and prophylactic Results Engraftment occured in 38/40 recipients (95%). Acute regimen intended to achieve high rates of engraftment with or chronic GVHD occurred in 18 (45%) and 5 (12.5%), respec- minimal graft-versus-host disease (GVHD) in allogeneic tively, with 6 episodes of grades III–IVand/or steroid refractory transplantation for chronic granulomatous disease in a single GVHD. Overall survival was 33/40 (82.5%) and event-free sur- center. vival was 30/40 (80%). Successful engraftment was associated Methods Forty patients, 37 male, with chronic granulomatous with myeloid and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Immunology Springer Journals

Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial

Loading next page...
 
/lp/springer_journal/allogeneic-reduced-intensity-hematopoietic-stem-cell-transplantation-3pq3qUssaO
Publisher
Springer US
Copyright
Copyright © 2017 by US Government (outside the USA)
Subject
Biomedicine; Immunology; Infectious Diseases; Internal Medicine; Medical Microbiology
ISSN
0271-9142
eISSN
1573-2592
D.O.I.
10.1007/s10875-017-0422-6
Publisher site
See Article on Publisher Site

Abstract

J Clin Immunol (2017) 37:548–558 DOI 10.1007/s10875-017-0422-6 ORIGINAL ARTICLE Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial 1 2 2 2 2 Mark Parta & Corin Kelly & Nana Kwatemaa & Narda Theobald & Diane Hilligoss & 3 4 5 5,6 2 Jing Qin & Douglas B. Kuhns & Christa Zerbe & Steven M. Holland & Harry Malech & Elizabeth M. Kang Received: 20 February 2017 /Accepted: 13 July 2017 /Published online: 28 July 2017 US Government (outside the USA) 2017 Abstract dose total body irradiation for MUD recipients) with sirolimus Purpose The purpose of this study was to evaluate engraft- graft-versus-host disease prophylaxis. ment and adverse events with a conditioning and prophylactic Results Engraftment occured in 38/40 recipients (95%). Acute regimen intended to achieve high rates of engraftment with or chronic GVHD occurred in 18 (45%) and 5 (12.5%), respec- minimal graft-versus-host disease (GVHD) in allogeneic tively, with 6 episodes of grades III–IVand/or steroid refractory transplantation for chronic granulomatous disease in a single GVHD. Overall survival was 33/40 (82.5%) and event-free sur- center. vival was 30/40 (80%). Successful engraftment was associated Methods Forty patients, 37 male, with chronic granulomatous with myeloid and

Journal

Journal of Clinical ImmunologySpringer Journals

Published: Jul 28, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off